Direct semiquantitative screening of drugs of abuse in serum and whole blood by means of CEDIA® DAU urine immunoassays

Journal of Analytical Toxicology

Volumn 23, Issue 4, 1999, Pages 247-256

  Iwersen Bergmann, Stefanie ^a   Schmoldt, Achim ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; METHADONE; METHAMPHETAMINE; MORPHINE; NITRAZEPAM; TETRAHYDROCANNABINOLIC ACID;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; HUMAN; IMMUNOASSAY; RELIABILITY; URINALYSIS;

EID: 0032807915     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/23.4.247     Document Type: Article

References (16)

1. E.L. Slightom and H.H. McCurdy. Enzyme immunoassay: novel approaches to tissue and fluid analysis. In Advances in Analytical Toxicology, Vol. 1. R.C. Baselt, Ed. Biomedical Publications, Foster City, CA, 1984, pp 9-40.
2. T.F. Simonick and V.W. Watts. Preliminary evaluation of the Abbott TDx for screening of d-methamphetamine in whole blood specimens. J. Anal. Toxicol. 16: 115-118 (1992).
3. W.M. Asselin, J.M. Leslie, and B. McKinley. Direct detection of drugs in whole hemolyzed blood using the EMIT dau urine assays. J. Anal. Toxicol. 12: 207-215 (1988).
4. H.W. Peel and B.J. Perrigo. Detection of cannabinoids in blood using EMIT. J. Anal. Toxicol. 5: 165-167 (1981).
5. L.J. Lewellen and H. McCurdy. A novel procedure for the analysis of drugs in whole blood by homogenous enzyme immunoassay. J. Anal. Toxicol. 12: 260-267 (1988).
6. C.E. McCord and J.R. McCutcheon. Preliminary evaluation of the Abbott TDx for benzoylecgonine and opiate screening in whole blood. J. Anal. Toxicol. 12: 295-297 (1988).
7. E.L. Slightom. The analysis of drugs in blood, bile and tissue with an indirect homogenous enzyme immunoassay. J. Forensic Sci. 23: 292-303 (1978).
8. W. Huang and D.E. Moody, Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood. J. Anal. Toxicol. 19: 333-342 (1995).
9. C.W. Lee and A.M. Lee. Evaluation of the Abbott TDx Analyzer. J. Anal. Toxicol. 13: 50-56 (1989).
10. S. Iwersen, A. Schmoldt, F. Schulz, and K. Püschel. Evidence of gestational heroin exposure by comparative analysis of fetal and maternal body fluids, tissues, and hair in a heroin-related death. J. Anal. Toxicol. 22: 296-298 (1998).
11. S. Iwersen and A. Schmoldt. One fatal and one nonfatal intoxication with tranylcypromine. Absence of amphetamines as metabolites. J. Anal. Toxicol. 20: 301-304 (1996).
12. J.C. Cagle, H.H. McCurdy, Y. Mary Pan, K.J. Ayton, W.H. Wall, and E.T. Solomons. Evaluation of the CEDIA™ DAU assays and the AxSym™ system for the analysis of cannabinoids in whole blood. J. Anal. Toxicol. 21: 213-217 (1997).
13. A.H.B. Wu, E. Forte, G. Casella, K. Sun, G. Hemphill, R. Foery, and H. Schanzenbach. CEDIA for Screening drugs of abuse in urine and the effect of adulterants. J. Forensic Sci. 40: 614-618 (1995).
14. M. Bogusz, R. Aderjahn, G. Schmitt, E. Nadler, and B. Neureither. The determination of drugs of abuse in whole blood by means of FPIA and Emit-dau immunoassays - a comparative study. Forensic Sci. Int. 48: 27-37 (1990).
15. R.D. Maier, M. Erkens, H. Hoenen, and M. Bogusz. The screening for common drugs of abuse in whole blood by means of EMIT-ETS and FPIA-ADx urine immunoassays. Int. J. Leg. Med. 105: 115-119 (1992).
16. C.R. Goodall and B.J. Basteyns. A reliable method for the detection, confirmation, and quantitation of cannbinoids in blood. J. Anal. Toxicol. 19: 419-426 (1995).